MetLife (MET) Tops Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts MET Hot Sheet
Price: $97.62 -1.62%
Revenue Growth %: +15.8%
Financial Fact:
Policyholder benefits and claims: 10.86B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.8%
Financial Fact:
Policyholder benefits and claims: 10.86B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MetLife (NYSE: MET) reported Q2 EPS of $1.94, $0.01 better than the analyst estimate of $1.93. Revenue for the quarter came in at $16.62 billion versus the consensus estimate of $16.98 billion.
For earnings history and earnings-related data on MetLife (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
